retatrutide trial results news today New weight-loss drug showing stronger than current options ✨ Big news in the

A randomised controlled trial of exenatide once-weekly in alcohol use disorder showed mixed results overall, with possible effects in certain subgroups

By covalent (albiglutide, dulaglutide) or no-covalent (semaglutide) coupling to larger molecules with slow clearance, analogs with even more prolonged activity have been produced so that there are now several once-weekly agonists on the market

Canagliflozin and cardiovascular and renal events in type 2 diabetes

What people complain about: Bundle pricing traps are the most serious complaint

Police in Uttarakhand, India arrested four pharmaceutical executives for their alleged involvement in a counterfeit medicine operation that distributed 1.8 million fake tablets bearing the packaging of prominent pharmaceutical companies between 2022 and 2025